Skip to main content
Caplight Logo









Nurotron Biotechnology Co., Ltd.

Nurotron Biotechnology Co., Ltd.

Private
HangzhouHealthcare & Life Scienceshttp://nurotron.com/

Last Round

Strategic

May 15, 2025

Est. Valuation

$378.8M

Total Funding Raised

$17M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Nurotron Biotechnology Co., Ltd. operates in Healthcare & Life Sciences and is based in Hangzhou. Its latest recorded funding round was a Strategic round in May 2025.

Nurotron Biotechnology Co., Ltd. is a medical device company that designs, develops, and manufactures neurostimulation systems, including cochlear implants, auditory brainstem implants, and other neural electrical stimulation rehabilitation products.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Nurotron Biotechnology Co., Ltd. Comparables

Compare Nurotron Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.

Nurotron Biotechnology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
TODOC
83%
Cochlear Limited
83%
Neubio
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Nurotron Biotechnology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicMay 15, 2025
StrategicMay 16, 2024
VC RoundJun 1, 2023
VC RoundFeb 1, 2021
StrategicSep 29, 2020
Early Funding
Aug 1, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Nurotron Biotechnology Co., Ltd. Investors

Notable investors and investment history

Nurotron Biotechnology Co., Ltd. investors
InvestorRounds
Hillhouse InvestmentStrategic
Zhejiang Sino Wisdom Investment ManagementSeries B Extension
Chenghe Capital ManagementPrivate Equity, VC Round
德同资本Series C
Yinrun CapitalEarly Funding
Tianyi GroupSeries B Extension
Zhejiang Jiuren Capital Management Co., Ltd.Private Equity
Book a demo to see all 13 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 29, 2026

    Grew 62% QoQ from 13 to 21 employees.

  • Jun 1, 2023

    Completed a VC Round fundraise.

Book a demo to see all signals

For institutional investors. Book with your work email.

Nurotron Biotechnology Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Nurotron Biotechnology Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Nurotron Biotechnology Co., Ltd.'s valuation, stock price, and market status.

Is Nurotron Biotechnology Co., Ltd. a public or private company?

Nurotron Biotechnology Co., Ltd. is a private company.

What is the current stock price of Nurotron Biotechnology Co., Ltd.?

Nurotron Biotechnology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Nurotron Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Nurotron Biotechnology Co., Ltd. worth (valuation)?

Nurotron Biotechnology Co., Ltd.'s valuation is estimated at $378.8M based on funding round data.

Can I buy Nurotron Biotechnology Co., Ltd. stock?

Nurotron Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Nurotron Biotechnology Co., Ltd.'s last funding round?

Nurotron Biotechnology Co., Ltd.'s most recent funding round was Strategic on May 15, 2025.

Who are the main investors in Nurotron Biotechnology Co., Ltd.?

Key investors in Nurotron Biotechnology Co., Ltd. include Qiming Venture Partners.

Will Nurotron Biotechnology Co., Ltd. IPO soon?

No public IPO plans have been announced for Nurotron Biotechnology Co., Ltd..

How can I track Nurotron Biotechnology Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades in Nurotron Biotechnology Co., Ltd.'s shares on secondary markets.

Firmographic Details

HeadquartersHangzhou
Employee Range4
Year Founded2006
Last FundingMay 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?